Skip to content
← Back to this collection

PUBLICATIONS · 33568345

Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Cancer Res
Publication date
2021 Jul 1
First author
Foster JH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Clin Cancer Res. 2021 Jul 1;27(13):3507-3509. doi: 10.1158/1078-0432.CCR-21-0627.
    note
    Source null
    related pmid
    33947691
    relationship
    Comment in

Authors and identifiers

  1. name
    Foster JH
    type
    Author
  2. name
    Voss SD
    type
    Author
  3. name
    Hall DC
    type
    Author
  4. name
    Minard CG
    type
    Author
  5. name
    Balis FM
    type
    Author
  6. name
    Wilner K
    type
    Author
  7. name
    Berg SL
    type
    Author
  8. name
    Fox E
    type
    Author
  9. name
    Adamson PC
    type
    Author
  10. name
    Blaney SM
    type
    Author
  11. name
    Weigel BJ
    type
    Author
  12. name
    Mossé YP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Foster JH
    type
    Author
  2. name
    Voss SD
    type
    Author
  3. name
    Hall DC
    type
    Author
  4. name
    Minard CG
    type
    Author
  5. name
    Balis FM
    type
    Author
  6. name
    Wilner K
    type
    Author
  7. name
    Berg SL
    type
    Author
  8. name
    Fox E
    type
    Author
  9. name
    Adamson PC
    type
    Author
  10. name
    Blaney SM
    type
    Author
  11. name
    Weigel BJ
    type
    Author
  12. name
    Mossé YP
    type
    Author
bibliography ids
  1. nci-bib-845b8a2d5ddb584b20f797d2
book metadata
content sha256
eebf3f1b016d2aed0d54e2e428c91a6adfd99b404d7212efbf1ac6f4477bcadf
document type
citation
dois
  1. 10.1158/1078-0432.CCR-20-4224
electronic publication date
display
2021 Feb 10
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:33568345
immutable id
pubmed:33568345@eebf3f1b016d2aed0d54e2e428c91a6adfd99b404d7212efbf1ac6f4477bcadf
journal
abbreviation
Clin Cancer Res
issn electronic
1557-3265
issn print
1078-0432
issue
13
name
Clinical cancer research : an official journal of the American Association for Cancer Research
nlm unique id
9502500
pages
3543-3548
volume
27
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Clin Cancer Res. 2021 Jul 1;27(13):3507-3509. doi: 10.1158/1078-0432.CCR-21-0627.
    note
    Source null
    related pmid
    33947691
    relationship
    Comment in
outcomes validated
false
pmid
33568345
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
9eaa4eca117c8b7a600dab0fc19bfa507e0e20d055b5a2f62031e7c9bb9d3f28
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jul 1
precision
day
year
2021
publication types
  1. Journal Article
  2. Research Support, N.I.H., Extramural
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33568345/
title
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).

Preserved source evidence · Not medical advice